Authors: Prashil Shetty, Dr. Harsha K. Rajasimha
The Hidden Weight Behind Every Trial: Understanding Site Burden
For biotech, pharma, and medtech companies advancing treatments in emerging disease areas such as rare diseases, obesity, oncology, and dermatology, success hinges on speed and efficiency.
Yet despite scientific progress, many sponsors underestimate a critical barrier: site burden.
Site burden refers to the growing operational load placed on clinical research sites. It isn’t a theoretical issue – it’s the logistical drag on timelines, data quality, and patient recruitment.
A recent Tufts CSDD report presented at the 2024 SCOPE Summit found that decentralized trial components have increased site burden by more than 25%, and site activation rates in North America have fallen to around 62% (Moe Alsumidaie, 2024).
Trials are becoming more complex—with longer durations, more endpoints, and evolving regulatory expectations—but site resources haven’t kept pace. For sponsors, that means more trial delays, compliance risks, and recruitment failures.
Site burden can lead to inefficiencies, delays, and increased risk of errors. Rather than focusing on advancing the trial, site staff often find themselves managing paperwork, scheduling, and data entry.
This challenge affects not only the day-to-day operations but also the overall success of clinical studies.
Trial Delays, Burnout, and Compliance Risks: The Real Cost of Burdened Sites
Site burden presents numerous challenges that directly impact the success of clinical trials. Nearly half of trial sites fail to meet enrollment goals, often because staff are consumed by administrative tasks—such as data entry, scheduling, and managing protocols—rather than focusing on patient recruitment and engagement.
Recruitment should be a shared responsibility. Sponsors must take an active role in providing tools, outreach strategies, and centralized resources to support recruitment, rather than relying entirely on overstretched site staff.
Operational inefficiencies are a leading cause of trial delays. Research indicates that approximately 85% of clinical trials encounter delays, with many stemming from manual scheduling, repetitive data entry, & slow communication at the site level (Iddo Peleg, 2024).
These delays can be extremely costly, with some estimates placing the cost of a single day’s delay at between $600,000 & $8 million, depending on the trial’s phase (Matthew Spott, 2024).
Adding to the complexity are Institutional Review Boards (IRBs). While centralized IRBs can streamline approval processes, many sites still rely on site-specific or institutional IRBs, each with its own timelines and requirements.
These inconsistencies cause variability in study startup timelines and compound delays across multi-site trials. Sponsors need to account for these structural differences early on to prevent activation bottlenecks.
The pressure on clinical research coordinators remains a significant concern. A recent study published in Mayo Clinic Proceedings analyzed burnout and work-life integration among U.S. physicians.
Although the study focused on physicians rather than clinical research staff specifically, it highlights ongoing challenges with burnout in healthcare professions. The research found that burnout levels among physicians remain high, approximately 45% in 2023.
This highlights the continuing stress that healthcare workers face. Given the similarities in job demands, clinical research coordinators are likely to experience comparable pressures, including administrative overload and the complexities of modern clinical trials.
Moreover, this issue is not confined to the U.S. clinical research teams; globally, they are grappling with these burdens, which can impact staff well-being and trial efficiency (Shanafelt et al., 2025).
Compliance risks also rise when site teams are overextended. Documentation errors, missed protocol deadlines, and delayed data submissions become more frequent, increasing the risk of audit findings and regulatory setbacks. These issues compromise data quality, trial integrity, and ultimately, patient safety.
Moreover, communication breakdowns between sites, sponsors, and contract research organizations (CROs) are common when site staff are overextended, leading to fragmented workflows and delayed problem resolution.
Without clear, real-time visibility into site operations, sponsors miss opportunities for proactive intervention, which further slows progress.
In sum, site burden is not just an internal challenge for research sites; it impacts recruitment, timelines, costs, data quality, and the overall success of clinical trials, ultimately affecting how quickly new treatments reach patients.
Lightening the Load: How Smart Tech Transforms Site Workflows
The demands on clinical trial sites go far beyond simple paperwork. Managing patient care, data collection, regulatory compliance, and communication, all while juggling multiple disconnected systems, can create a complex, fragmented workflow that’s difficult to sustain.
Sponsors often introduce point solutions to help sites manage trials—such as electronic diaries, data entry portals, and lab trackers—but these tools aren’t always integrated.
A typical site may need to log into separate systems for each sponsor, manage multiple dashboards, and maintain manual records just to stay compliant. For sites participating in multiple studies (prevalent in oncology and rare disease trials), this becomes a logistical nightmare.
Patient engagement is another critical area impacted by site burden. Without automated scheduling and reminders, missed visits and dropouts become more common, threatening study timelines and data integrity.
Technology can automate appointment reminders and centralize patient tracking to improve retention and adherence.
High staff turnover also adds to the burden. Constantly onboarding and training new coordinators is time-consuming and costly. Platforms with standardized workflows and intuitive interfaces reduce the learning curve, enabling new staff to get up to speed more quickly.
Preparing for audits is often a stressful process when documentation is scattered or incomplete. Digital document management systems organize files securely and make regulatory documents readily accessible, streamlining audit preparation and ensuring compliance with regulations such as 21 CFR Part 11.
Timely monitoring and reporting are crucial to trial success; however, traditional manual reporting methods often cause delays in oversight and decision-making.
Real-time dashboards provide immediate visibility into enrollment status, data quality, and site performance, enabling sponsors and contract research organizations (CROs) to spot and resolve issues quickly.
Keeping up with protocol amendments can be challenging, especially when changes aren’t communicated effectively. Automated update distribution ensures that all site staff are working with the latest information, reducing errors and ensuring consistent adherence to protocol.
Finally, without clear insight into workload and resource use, sites may struggle to allocate staff and materials efficiently. Data-driven insights from ctms software help optimize resource planning, ensuring the right people are focused on the right tasks at the right time.
Real Impact: How Jeeva Eases the Day-to-Day for Sites
Beyond the features, what truly matters is how technology like Jeeva changes the everyday experience for clinical trial teams. Sites using Jeeva have reported noticeable reductions in administrative workload, allowing coordinators and staff to dedicate more time to patient care and data quality.
Unlike traditional approaches that rely on siloed tools and third-party integrations, Jeeva offers a unified, cloud-native platform designed to minimize technical complexity and streamline site operations from the ground up. Its integration with IQVIA—One Home For Sites, expands accessibility while providing single sign-on access to core functionalities, including scheduling, eConsent, document management, and reporting. This simplifies training for new coordinators and reduces reliance on manual reconciliation.
Automated reminders and centralized scheduling help decrease missed visits and improve patient retention, positively impacting study timelines. Streamlined document management simplifies audit preparation, reducing the stress and delays caused by disorganized records.
Standardized workflows and an intuitive interface make onboarding new staff more efficient, helping teams stay productive even during periods of high turnover.
Real-time dashboards and progress tracking provide clear visibility to all stakeholders, improving coordination and enabling faster resolution of emerging issues.
AI-powered capabilities within Jeeva actively support site operations by analyzing usage patterns, participant behavior, and task flows to help coordinators prioritize work, flag anomalies, and optimize resource allocation.
The system also identifies data inconsistencies early, supporting proactive data quality management without requiring additional steps for staff.
These practical improvements result in time savings of up to 60% in administrative tasks for some sites, leading to reduced burnout and increased focus on what matters most: delivering high-quality trials through advanced clinical trials software and supporting patients.
While every site’s needs are unique, early adopters of Jeeva consistently note that reducing the day-to-day burden is key to maintaining trial momentum and ensuring high-quality data collection.
Rethinking Site Burden: A Path Toward Smarter Trials
Site burden isn’t just a site problem—it’s a sponsor problem. For emerging biotech companies, every delay in enrollment or protocol deviation can jeopardize funding, partnerships, and patient access.
You can’t afford to lose time or data quality to administrative overload at the site level.
Instead of handing sites a fragmented tech stack and expecting seamless execution, sponsors must treat sites as strategic partners.
That starts by simplifying their day-to-day experience: fewer systems, fewer logins, and fewer workarounds. Platforms like Jeeva, integrated with IQVIA and designed for single-login access, remove the noise, helping sites stay focused on recruitment, retention, and compliance.
The takeaway is clear: reducing site burden isn’t just an operational improvement, it’s a strategic advantage.
Biotechs that proactively support their sites with unified, intuitive clinical research software will see faster startup, cleaner data, and better outcomes.
Smarter trials begin with smarter sponsor support—and that support should be as streamlined as the science behind your innovation.
References
1. Iddo Peleg. (2024, December 18). Future Trends for Clinical Trials in 2025 and Beyond – MedCity News. https://medcitynews.com/2024/12/future-trends-for-clinical-trials-in-2025-and-beyond/
2. Matthew Spott. (2024, November 19). The Cost of a One-Day Delay in a Clinical Trial: Understanding the Economic, Scientific, and Human Impact | LinkedIn. https://www.linkedin.com/pulse/cost-one-day-delay-clinical-trial-understanding-human-matthew-qfhie/
3. Moe Alsumidaie. (2024, March 19). Tufts CSDD: New Insights on The Clinical Trial Industry. https://www.clinicaltrialvanguard.com/conference-coverage/tufts-csdd-new-insights-on-the-clinical-trial-industry/
4. Shanafelt, T. D., West, C. P., Sinsky, C., Trockel, M., Tutty, M., Wang, H., Carlasare, L. E., & Dyrbye, L. N. (2025). Changes in Burnout and Satisfaction With Work–Life Integration in Physicians and the General US Working Population Between 2011 and 2023. Mayo Clinic Proceedings, 0(0). https://doi.org/10.1016/J.MAYOCP.2024.11.031
Read More: Revolutionize Clinical Trials: How Jeeva eClinical Cloud Maximizes the Success Rate of Your Study!